James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $562.91 ($5.7M) on 2026-05-18, disclosed to the SEC on 2026-05-19.
Scheduled sale ($5.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $562.91 | 200 | $113K | 2.0% |
| 2 | $564.30 | 422 | $238K | 4.2% |
| 3 | $565.44 | 2,131 | $1.2M | 21.2% |
| 4 | $566.39 | 1,796 | $1.0M | 17.9% |
| 5 | $568.43 | 1,304 | $741K | 13.1% |
| 6 | $568.48 | 2,785 |
| $1.6M |
| 27.9% |
| 7 | $569.56 | 1,322 | $753K | 13.3% |
| 8 | $570.18 | 40 | $23K | 0.4% |
| Total | $567.31 avg | 10,000 | $5.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |